On this page
Arthur A Torres
Insider
First SEC filing: June 20, 2024 · Latest: June 20, 2024
Insider at
Insider transactions
0 buys (P)
2 sells (S)
Net: $-214,650
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | CDNA | S | 6,484 | $19.89 | $128,967 | 38,665 Direct | -14.36% | Disposed | 251.2% (price as of 2026-10-05) |
| May 14, 2026 | CDNA | S | 4,086 | $20.97 | $85,683 | 45,149 Direct | -8.30% | Disposed | 233.1% (price as of 2026-10-05) |
| June 13, 2025 | CDNA | A | 12,103 | · | · | 49,235 Direct | +32.59% | Acquired | (price as of 2026-10-05) |
| June 14, 2024 | CDNA | A | 16,048 | · | · | 16,048 Direct | · | Acquired | (price as of 2026-10-05) |
| June 14, 2024 | CDNA | A | 16,048 | · | · | 16,048 Direct | · | Acquired | (price as of 2026-10-05) |
| June 14, 2024 | CDNA | A | 10,570 | · | · | 37,132 Direct | +39.79% | Acquired | (price as of 2026-10-05) |
| June 16, 2023 | CDNA | A | 29,136 | · | · | 29,136 Direct | · | Acquired | (price as of 2026-10-05) |
| June 16, 2023 | CDNA | A | 18,844 | · | · | 26,562 Direct | +244.16% | Acquired | (price as of 2026-10-05) |
| June 16, 2022 | CDNA | A | 7,606 | · | · | 7,606 Direct | · | Acquired | (price as of 2026-10-05) |
| June 16, 2022 | CDNA | A | 4,863 | · | · | 7,718 Direct | +170.33% | Acquired | (price as of 2026-10-05) |
| Nov. 5, 2021 | CDNA | P | 600 | $47.62 | $28,572 | 2,855 Direct | +26.61% | Acquired | 46.7% (price as of 2026-10-05) |
| Sept. 15, 2021 | CDNA | A | 2,255 | · | · | 2,255 Direct | · | Acquired | (price as of 2026-10-05) |
| Sept. 15, 2021 | CDNA | A | 2,255 | · | · | 2,255 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 14, 2024 | CDNA | Stock Option (right to buy) | Common Stock | · | June 14, 2034 | 16,048 | Acquired |
| June 14, 2024 | CDNA | Stock Option (right to buy) | Common Stock | $9.35 | June 14, 2034 | 16,048 | Acquired |
| June 16, 2023 | CDNA | Common Stock | Common Stock | $7.96 | June 16, 2033 | 29,136 | Acquired |
| June 16, 2022 | CDNA | Common Stock | Common Stock | $20.56 | June 16, 2032 | 7,606 | Acquired |
| Sept. 15, 2021 | CDNA | Stock Option (right to buy) | Common Stock | $66.51 | Sept. 15, 2031 | 2,255 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).